Notice Of Intent for Gene Production and Protein Expression Services

Closed Solicitation Posted

Solicitation number
NOI-NIAID-23-2176003
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases intends to negotiate a sole source contract with Genscript USA, Inc. for Gene Production and Protein Expression Services. This follow-on requirement has continuity of protocol and requirements. Interested parties may submit a capability statement by August 21, 2023 to be considered, however award remains at the agency's discretion.

This requirement has no set-aside designations. The NAICS code is 541380 for Testing Laboratories and Services. The potential place of performance is Bethesda, Maryland. Gene Production and Protein Expression Services will support research efforts of the National Institute of Allergy and Infectious Diseases located in Bethesda. The statutory authority cited is 41 U.S.C. 1901(a)(1) for contracts with only one responsible source where no other will satisfy agency requirements.

Notice text

Notice Of Intent NOI-NIAID-23-2176003

NAICS – 541380 - Testing Laboratories and Services

This is a Notice of Intent, not a request for proposal.  The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Genscript USA, INC. for Gene Production and Protein Expression Services. This is a follow-on requirement that has a continuity protocol and requirements.

The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.  All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-23-2176003 to Jesse Weidow at jesse.weidow@nih.gov, by 11:00 AM eastern standard time Monday, August 21, 2023. All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Similar open opportunities

Opportunity Agency Set-aside Responses due
RNA sequencing and whole genome sequencing services Bethesda, Maryland 20892, United States · NAICS 32599 Office of Logisitics and Acquisition Operations No set-aside
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) Bethesda, Maryland 20892, United States · NAICS 811210 National Institute of Allergy and Infectious Diseases No set-aside
NOI - DNA Sequencing of Bone Marrow Failure Syndro NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
Pre-Clinical Models of Infectious Diseases United States · NAICS 541714 National Institute of Allergy and Infectious Diseases No set-aside
NOI - 4D-Nucleofector Core Unit and X Unit NAICS 334516 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors